Second and later-line erlotinib use in non-small cell lung cancer: real world outcomes and practice patterns overtime in Canada
Perdrizet K, Sutradhar R, Li Q, Liu N, Earle CC, Leigh NB. J Thorac Dis. 2021;13(9):5419-29. Epub 2021 Sep 1.
Publications
High-intensity vs low-intensity knowledge translation interventions for surgeons and their association with process and outcome measures among patients undergoing rectal cancer surgery
Simunovic M, Urbach DR, Fahim C, O’Brien MA, Earle CC, Brouwers M, Gatov E, Grubac V, McCormack D, Baxter N. JAMA Netw Open. 2021; 4(7):e2117536. Epub 2021 July 16.
Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+)
Seow H, Tanuseputro P, Barbera L, Earle CC, Guthrie DM, Isenberg SR, Juergens RA, Myers J, Brouwers M, Tibebu S, Sutradhar R. Palliat Med. 2021; 35(9):1713-23. Epub 2021 Jun 15.
Impact of palliative care involvement on end-of-life care patterns among adolescents and young adults with cancer: a population-based cohort study
Kassam A, Gupta A, Rapoport A, Srikanthan A, Sutradhar R, Luo J, Widger K, Wolfe J, Earle C, Gupta S. J Clin Oncol. 2021; 39(22):2506-15. Epub 2021 Jun 7.
Impact of geography on care delivery and survival for noncurable pancreatic adenocarcinoma: a population-based analysis
Yee EK, Coburn NG, Davis LE, Mahar AL, Zuk V, Gupta V, Liu Y, Earle CC, Hallet J. J Natl Compr Canc Netw. 2020; 18(12):1642-50. Epub 2020 Dec 2.
Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada
Dai WF, Beca J, Croxford R, Isaranuwatchai W, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Mercer RE, Hanna TP, Chan KKW. Int J Cancer. 2021; 148(8):1910-8. Epub 2020 Oct 26.
Real-world costs of azacitidine treatment in patients with higher-risk myelodysplastic syndromes/low blast-count acute myeloid leukemia
Mozessohn L, Cheung MC, Mittmann N, Earle CC, Liu N, Buckstein R. JCO Oncol Pract. 2021; 17(4):e517-25. Epub 2020 Sep 21.
The impact of routine Edmonton symptom assessment system use on receiving palliative care services: results of a population-based retrospective-matched cohort analysis
Barbera L, Sutradhar R, Earle CC, Howell D, Mittmann N, Li Q, Thiruchelvam D, Seow H. BMJ Support Palliat Care. 2023; 13(e1):e144-9. Epub 2020 Sep 17.
The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: results of a population‐based retrospective matched cohort analysis
Barbera L, Sutradhar R, Seow H, Mittmann N, Howell D, Earle CC, Li Q, Thiruchelvam D. Cancer Med. 2020; 9(19):7107-15. Epub 2020 Aug 14.
Does the presence of an intact primary increase the risk of non‐elective colorectal surgery in patients treated with Bevacizumab
Baxter NN, Sutradhar R, Dossa F, Fu L, Rochon P, Wei AC, Kennedy ED, Earle CC. Colorectal Dis. 2020; 22(12):1974-83. Epub 2020 Aug 7.